Richard Sullivan
Researcher Next ID · RN-033062
Researcher · Economics, Econometrics and Finance
University of British Columbia
Vancouver, Canada
- Works count
- 804
- Citation count
- 39,180
- H-index
- 82
- i10-index
- 368
Research interests
Publications
Cancer in sub-Saharan Africa: a Lancet Oncology Commission
The Lancet Oncology · 2022 · 10.1016/s1470-2045(21)00720-8
Priorities for cancer research in low- and middle-income countries: a global perspective
Nature Medicine · 2022 · 10.1038/s41591-022-01738-x
The Lancet Commission on diagnostics: transforming access to diagnostics
The Lancet · 2021 · 10.1016/s0140-6736(21)00673-5
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00493-9
Sustainable care for children with cancer: a Lancet Oncology Commission
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30022-x
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study
BMJ Open · 2020 · 10.1136/bmjopen-2020-043828
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
The Lancet Oncology · 2020 · 10.1016/s1470-2045(20)30388-0
Mortality due to cancer treatment delay: systematic review and meta-analysis
BMJ · 2020 · 10.1136/bmj.m4087
The global burden of women’s cancers: a grand challenge in global health
The Lancet · 2016 · 10.1016/s0140-6736(16)31392-7
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Annals of Oncology · 2015 · 10.1093/annonc/mdv249
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00223-5
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development
The Lancet · 2015 · 10.1016/s0140-6736(15)60160-x
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development
American Journal of Obstetrics and Gynecology · 2015 · 10.1016/j.ajog.2015.04.010
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development
International Journal of Obstetric Anesthesia · 2015 · 10.1016/j.ijoa.2015.09.006
Economic Burden of Bladder Cancer Across the European Union
European Urology · 2015 · 10.1016/j.eururo.2015.10.024
Challenges to effective cancer control in China, India, and Russia
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70029-4
Delivery of affordable and equitable cancer care in India
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70117-2
The growing burden of cancer in India: epidemiology and social context
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70115-9
The burden of disease in older people and implications for health policy and practice
The Lancet · 2014 · 10.1016/s0140-6736(14)61347-7
Planning cancer control in Latin America and the Caribbean
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70048-2
Economic burden of cancer across the European Union: a population-based cost analysis
The Lancet Oncology · 2013 · 10.1016/s1470-2045(13)70442-x
Delivering affordable cancer care in high-income countries
The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70141-3
Hypoxia-driven selection of the metastatic phenotype
Cancer and Metastasis Reviews · 2007 · 10.1007/s10555-007-9062-2
Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicine
Perspectives in biology and medicine · 2006 · 10.1353/pbm.2006.0034
Oxygen-induced retinopathy in the mouse.
PubMed · 1994
Current projects
No projects listed.